The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oaktree Releases Open Letter to Ranger Shareholders

8 Jun 2018 07:00

Funds managed by Oaktree Capital Management, L.P. (“Oaktree”), an approximately 19% shareholder of Ranger Direct Lending Fund PLC (LON: RDL) (“Ranger” or “RDLF” or “the Company”), today released an open letter to Ranger shareholders.

The full text of the letter follows:

June 8, 2018

Dear fellow Ranger shareholders,

The Board’s latest response to our open letter dated June 6, 2018 raises a number of troubling questions which we urge the Board to answer without delay:

1. Why is the Board selectively engaging with only a minority of shareholders about the future of our Company, and disadvantaging others with dissenting views?

The Board inaccurately claims that Oaktree declined to participate in the review process, while “Independent Directors and their advisers continue to be in positive discussions with shareholders on the Ares proposal and related matter”. In reality, the Board and its advisor, Kinmont, repeatedly sidelined and delayed Oaktree’s ability to participate in the process alongside other shareholders, culminating in their giving us a direct ultimatum that we could only have a meeting with Ares if we agreed in advance to support their desired outcome. Since the beginning, Oaktree has advocated considering all strategic alternatives and has continually called on the Board to conduct an open and fair strategic review process. Oaktree remains open and ready to meet with Ares to hear how they plan to address our concerns, if the Board offers a meeting without self-serving preconditions. However, despite our extensive attempts to engage constructively with the Board, it has chosen to engage solely with a minority of RDLF shareholders supportive of its views on the direction of the Company. We also continue to question the Board’s statement that it has the support of 39% of shareholders on its recommendation to appoint Ares as the new investment manager, considering that to date based on our own stakeholder conversations we believe that a significant majority of shareholders share our concerns about the current Board’s stewardship.

2. Are the Board and its advisor conflicted?

We consider that the Board’s failure to meaningfully engage with Oaktree and other shareholders who have expressed dissenting views brings into question the independence of the current directors and the Board’s relationship with Kinmont. In the spirit of transparency, we call on the Board to publicly disclose the following with utmost urgency:

What dealings and discussions has each director had in recent years with Ares and its affiliates outside of RDLF? Is the Board’s key advisor Kinmont misaligned with shareholders due to compensation primarily based on placing a new manager, and not based on maximizing shareholder value?

3. Is the Board reneging on its commitment to allow shareholders a vote on the Ares proposal?

The latest letter is a clear admission on the part of the Board that the Ares proposal is not yet ready to be voted on by shareholders despite being promised “as soon as possible” on May 1, and later on May 16, “with the intention, if possible, of calling a general meeting on the same date as is proposed for the Company's AGM”. In fact, the Board continues to refer to an Ares-focused GM circular, but shareholders have yet to see this circular, suggesting that, once again, the Board is opting for gamesmanship and is not going to give shareholders the opportunity to vote on the Ares proposal on June 19. We find this fact pattern alarming, and we strongly urge the Board to fulfill its commitments and fiduciary responsibilities by ensuring all shareholders have a vote on this crucial decision as soon as possible.

Oaktree strongly believes this Board has demonstrated that it is not fit for purpose at such a critical moment in the Company’s history. In our view, the Board’s weaknesses can only be resolved by adding to the Board and introducing improved oversight, a broader range of views and deeper relevant experience at this important time for the Company.

Oaktree’s highly qualified nominees, Greg Share and Dominik Dolenec, have over 40 years of combined valuable experience that will strengthen the Board at this critical juncture. Our nominees are committed to representing the best interests of all shareholders and driving value, and their interests are fully aligned with those of all RDLF shareholders.

We urge shareholders to act now to maximize the value of their investment – vote FOR resolutions 8 and 9 for our highly qualified nominees Greg Share and Dominik Dolenec, who will be committed to driving value for all shareholders, to be appointed to the Board. The Annual General Meeting takes place on Tuesday, June 19, 2018, and it is important to vote on or before Friday, June 15, 2018 to have your voice heard.

If shareholders have questions, or need assistance in voting shares, please call: Georgeson, +44 (0) 207 019 7032 or email anthony.kluk@georgeson.com.

Sincerely,/s/ Patrick M. McCaneyPatrick M. McCaneyManaging Director and Portfolio ManagerValue EquitiesOaktree Capital Management, L.P.

About Oaktree

Oaktree is a leader among global investment managers specializing in alternative investments, with $121 billion in assets under management as of March 31, 2018. The firm emphasizes an opportunistic, value-oriented and risk-controlled approach to investments in credit, private equity, real assets and listed equities. The firm has over 900 employees and offices in 18 cities worldwide. For additional information, please visit Oaktree’s website at http://www.oaktreecapital.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180607006375/en/

Copyright Business Wire 2018

Date   Source Headline
25th Jan 202111:50 amRNSPortfolio Update
12th Jan 20211:12 pmRNSResult of General Meeting
23rd Dec 20207:00 amRNSPortfolio Update
21st Dec 20204:59 pmRNSPublication of Delisting Circular and Notice of GM
21st Dec 20204:59 pmRNSHolding(s) in Company
10th Dec 20205:20 pmRNSDividend Declaration
27th Nov 20205:37 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSChange of AIFM and intention to delist
24th Nov 202010:31 amRNSPortfolio Update
26th Oct 20209:56 amRNSPortfolio Update
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:36 pmRNSPrice Monitoring Extension
12th Oct 20207:00 amRNSPortfolio Update
22nd Sep 20207:00 amRNSHalf-year Report
16th Sep 20204:34 pmRNSDirector Declaration
9th Sep 202012:31 pmRNSPortfolio Update
20th Aug 202012:07 pmRNSSecond Price Monitoring Extn
20th Aug 202012:02 pmRNSPrice Monitoring Extension
22nd Jul 20209:43 amRNSPortfolio Update
9th Jul 202011:16 amRNSDirector Declaration
30th Jun 20203:37 pmRNSResult of AGM
24th Jun 20202:48 pmRNSPortfolio Update
8th Jun 20204:41 pmRNSSecond Price Monitoring Extn
8th Jun 20204:35 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSAnnual Financial Report
28th May 20206:00 pmRNSRevised Publication Date For The Annual Report
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
4th May 202011:21 amRNSPortfolio Update
30th Apr 20202:41 pmRNSPublication Date for Annual Report
27th Apr 20209:58 amRNSDisclosure of Rights Attaching to Equity Shares
7th Apr 20207:00 amRNSDividend Declaration
2nd Apr 202010:54 amRNSResignation of Director
30th Mar 20202:02 pmRNSPortfolio Update
16th Mar 20207:00 amRNSPrinceton Update
11th Mar 20207:00 amRNSPortfolio Update
20th Feb 20205:06 pmRNSPrinceton Update
3rd Feb 20207:00 amRNSPortfolio Update
17th Jan 20209:44 amRNSHolding(s) in Company
10th Jan 20204:41 pmRNSPrinceton Update
9th Jan 202012:11 pmRNSDividend Declaration
31st Dec 201911:18 amRNSUpdate - Standstill Agreement
24th Dec 201910:11 amRNSHolding(s) in Company
23rd Dec 20194:49 pmRNSPortfolio Update
10th Dec 201910:12 amRNSDirector Declaration
26th Nov 201911:29 amRNSPortfolio Update
26th Nov 20197:00 amRNSDividend Declaration
6th Nov 201910:07 amRNSPortfolio Update
28th Oct 20194:50 pmRNSDirector Declaration
24th Oct 201911:21 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.